Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zagaceta, Jorge ^a   Zulueta, Javier J ^a   Bastarrika, Gorka ^a   Colina, Inmaculada ^a   Alcaide, Ana B ^a   Campo, Arantza ^a   Celli, Bartolome R ^b   de Torres, Juan P ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SALBUTAMOL; ALBUMINOID; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

6 MINUTE WALKING DISTANCE; ADIPOSE TISSUE; ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; GENDER; HUMAN; HYPERTENSION; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MODIFIED MEDICAL RESEARCH COUNCIL SCORE; RISK FACTOR; SCORING SYSTEM; THORAX RADIOGRAPHY; AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; EXERCISE; GLUCOSE BLOOD LEVEL; LUNG; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; PERICARDIUM; RADIOGRAPHY; SMOKING;

ADIPOSE TISSUE; AGED; ALBUMINS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; EXERCISE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PERICARDIUM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 84878789856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065593     Document Type: Article

References (50)

1. Murray CJ, Lopez AD, (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
2. Sin DD, Man SF, (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2: 8-11.
3. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
4. Sin DD, Anthonisen NR, Soriano JB, Agusti AG, (2006) Mortality in COPD: role of comorbidities. Eur Respir J 28: 1245-1257.
5. Iwamoto H, Yokoyama A, Kitahara I, Ishikawa N, Haruta I, et al. (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179: 35-40.
6. Sin DD, Man SF, (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 107: 1514-9.
7. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, et al. (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 176: 1208-14.
8. van Gestel YR, Flu WJ, van Kuijk JP, Hoeks SE, Bax JJ, et al. (2010) Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med. 104: 712-6.
9. Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, et al. (2012) Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J. 39: 846-54.
10. Casanova C, de Torres JP, Navarro J, Aguirre-Jaíme A, Toledo P, et al. (2010) Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182: 1004-10.
11. Iacobellis G, Malavazos AE, Corsi MM. (2011) Epicardial fat: from the biomolecular aspects to clinical practice. The Int J of Bioch & Cell Biol.; 1651-1654.
12. Sacks HS, Fain JN, (2007) Human epicardial adipose tissue: a Review. Am Heart J. 153: 907-17.
13. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, et al. (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 88: 5163-8.
14. Kessels K, Cramer MJ, Velthuis B, (2006) Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular disease. Heart. 92: 962.
15. Abbara S, Desai JC, Cury RC, Butler J, Nieman K, et al. (2006) Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol. 57: 417-22.
16. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, et al. (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 117: 605-13.
17. Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, et al. (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 90: 499-504.
18. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2012) Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. [Epub ahead of print] Aug 9.
19. The Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. (2003) U. S. Department of Health and Human Services. National Institutes of Health. NHLBI. NIH Publication No. 03-5233. December 2003.
20. American Thoracic Society Statement. Lung function testing; selection of reference values and interpretative strategies (1991) Am Rev Resp Dis. 144: 1202-1218.
21. ATS Statement: Guidelines for the Six-Minute Walk Test, (2002) Am J Respir Crit Care Med. 166: 111-117.
22. Mahler D, Weels C, (1988) Evaluation of clinical methods for rating dyspnea. Chest. 93: 580-586.
23. Celli BR, Cote C, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012.
24. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753.
25. Shemesh J, Henschke C, Shaham D, Yip R, Farooqi AO, et al. (2010) Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 257: 541-548.
26. van den Borst B, Gosker HR, Schols AMWJ, (2013) Central fat and peripheral muscle. Partners in crime in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187: 8-13.
27. van den Borst B, Gosker HR, Koster A, Yu B, Kritchevsky SB, (2012) The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr. 96: 516-26.
28. Furutate R, Ishii T, Wakabayashi R, Motegi T, Yamada K, et al. (2011) Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 6: 423-30.
29. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, et al. (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 108: 2460-6.
30. Willens HJ, Byers P, Chirinos JA, Labrador E, et al. (2007) Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol. 99: 1242-5.
31. Iacobellis G, Leonetti F J, (2005) Epicardial adipose tissue and insulin resistance in obese subjects. Clin Endocrinol Metab. 90: 6300-2.
32. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, et al. (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 117: 605-13.
33. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, et al. (2009) Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 30: 850-6.
34. Agusti A, Macnee W. (2012) The COPD control panel: towards personalised medicine in COPD. Thorax. 2012 Nov 1. [Epub ahead of print].
35. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 365: 395-409.
36. de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S, et al. (2011) Lung cancer in patients with chronic obstructive pulmonary disease: incidence and predicting factors. Am J Respir Crit Care Med. 184: 913-9.
37. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, et al. (2012) Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 185: 44-52.
38. Martínez-García MÁ, Soler-Cataluña JJ, Donat Sanz Y, Catalán Serra P, Agramunt Lerma M, et al. (2011) Factors associated with bronchiectasis in patients with COPD. Chest. 140: 1130-7.
39. Wells JM, Washko GR, Han MK, Abbas N, Nath H, et al. (2012) N Engl J Med. 367: 913-21.
40. Casanova C, de Torres JP, Navarro J, Aguirre-Jaíme A, Toledo P, et al. (2010) Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 182: 1004-10.
41. Diercks GF, Van Boven AJ, Hillege JL, de Jong PE, Rouleau JL, et al. (2002) The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 18: 525-535.
42. Nakazato R, Rajani R, Cheng VY, Shmilovich H, Nakanishi R, et al. (2012) Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis. 220: 139-44.
43. Kim MK, Tomita T, Kim MJ, Sasai H, Maeda S, et al. (2009) Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol. 106: 5-11.
44. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, et al. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 171: 972-7.
45. Dagvasumberel M, Shimabukuro M, Nishiuchi T, Ueno J, Takao S, et al. (2012) Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjects. Cardiovasc Diabetol. 11: 106.
46. Samaras K, Botelho NK, Chisholm DJ, Lord RV, (2010) Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health. Obes Surg. 20: 108-13.
47. Klimcakova E, Roussel B, Kovacova Z, Kovacikova M, Siklova-Vitkova M, et al. (2011) Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia. 54: 876-87.
48. Almendros I, Farré R, Planas AM, Torres M, Bonsignore MR, et al. (2011) Tissue oxygenation in brain, muscle, and fat in a rat model of sleep apnea: differential effect of obstructive apneas and intermittent hypoxia. Sleep. 34: 1127-33.
49. Nakagawa Y, Kishida K, Kihara S, Yoshida R, Funahashi T, et al. (2011) Nocturnal falls of adiponectin levels in sleep apnea with abdominal obesity and impact of hypoxia-induced dysregulated adiponectin production in obese murine mesenteric adipose tissue. J Atheroscler Thromb. 18: 240-7.
50. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al. (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 186: 155-61.